Safety and tolerability of apomorphine sublingual film and subcutaneous apomorphine for the treatment of OFF episodes in Parkinson's disease

被引：0
|
作者：
Rascol, O.
Poewe, W.
Stocchi, F.
Chaudhuri, R.
Kassube, J.
Manzanares, L. Lopez
Leta, V.
Zhang, I.
Bowling, A.
Wu, S.
Pappert, E.
机构：
来源：
MOVEMENT DISORDERS | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
760
引用
收藏
页码：S348 / S348
页数：1
相关论文
共 50 条
  • [31] Apomorphine Sublingual Film for "OFF" Episodes in Parkinson's Disease: Impact of Concomitant Antiemetics on Nausea and Vomiting
    Hauser, R.
    Factor, S.
    Ondo, W.
    Zhang, I.
    Pappert, E.
    Navia, B.
    MOVEMENT DISORDERS, 2021, 36 : S175 - S175
  • [32] Motor Responses to Apomorphine Sublingual Film Compared With Levodopa in Patients With Parkinson's Disease and "OFF" Episodes
    Hui, Jennifer
    Fox, Susan
    Neeson, William
    Sciarappa, Kenneth
    Pappert, Eric
    Navia, Bradford
    NEUROLOGY, 2021, 96 (15)
  • [33] A Thorough QT Study of Apomorphine Sublingual Film in Patients With Parkinson's Disease Complicated By "OFF" Episodes
    Stocchi, F.
    Wilks, K. L.
    Peckham, E. L.
    De Pandis, M. F.
    Sciarappa, K.
    Agbo, A.
    Kleiman, R.
    Blum, D.
    Navia, B.
    MOVEMENT DISORDERS, 2019, 34 : S12 - S12
  • [34] APOMORPHINE SUBLINGUAL FILM DOES NOT WORSEN DYSKINESIA IN THE LONG-TERM TREATMENT OF "OFF" EPISODES IN PARKINSON'S DISEASE
    Klos, K. J.
    Hui, J. S.
    Zhang, I.
    Navia, B.
    Pappert, E.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 42 - 42
  • [35] Cost-Effectiveness of Apomorphine Sublingual Film as an "On-Demand" Treatment for "OFF" Episodes in Patients with Parkinson's Disease
    Thach, Andrew
    Kirson, Noam
    Zichlin, Miriam L.
    Dieye, Ibrahima
    Pappert, Eric
    Williams, G. Rhys
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (02): : 110 - +
  • [36] Sublingual apomorphine in the treatment of Parkinson's disease
    Kassubek, Jan
    Jost, Wolfgang H.
    Schwarz, Johannes
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (10) : 1209 - 1216
  • [37] Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson's disease
    Agbo, Felix
    Crass, Ryan L.
    Chiu, Yu-Yuan
    Chapel, Sunny
    Galluppi, Gerald
    Blum, David
    Navia, Bradford
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (04): : 1464 - 1475
  • [38] Efficacy of sublingual apomorphine (APL-130277) for the treatment of "off" episodes in patients with Parkinson's disease
    Hauser, R. A.
    Dubow, J.
    Dzyngel, B.
    Bilbault, T.
    Giovinazzo, A.
    Agro, A.
    MOVEMENT DISORDERS, 2015, 30 : S90 - S90
  • [39] Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease
    Hauser, Robert
    Dzyngel, Bruce
    Bilbault, Thierry
    Shill, Holly
    Argo, Albert
    NEUROLOGY, 2016, 86
  • [40] Efficacy of Sublingual Apomorphine (APL-130277) for the Treatment of "Off" Episodes in Patients with Parkinson's Disease
    Hauser, Robert A.
    Dubow, Jordan
    Dzyngel, Bruce
    Bilbault, Thierry
    Giovinazzo, Anthony
    Shill, Holly
    Agro, Albert
    ANNALS OF NEUROLOGY, 2015, 78 : S44 - S44
12345